Results per Page:
Fred Hutch researchers receive prestigious R01 awards
NIH-funded awards will support multi-year investigations into HIV reservoirs, biomarkers of vaccine efficacy and how PrEP influences antibody pharmacokinetics
Does solar jet lag contribute to liver cancer?
Fred Hutch researcher will use American Cancer Society grant to determine if circadian disruption increases risk for hepatocellular carcinoma
Confused about cancer? 1.800.4.CANCER is here to help
The taxpayer-supported National Cancer Institute contact center is based at Fred Hutch Cancer Center
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 30, 2026
A swing and a swing and a hit: DNA control of RecBCD conformation and activity
From the Smith Lab, Basic Sciences Division
How chronic graft-versus-host disease unfolds ten years after transplant
From the Lee Lab, Clinical Research Division
Fred Hutch brings together rare cancer community
Patients and caregivers share frustrations, practical realities of rare cancer life at TRACER program’s first education symposium
A group retreat model for psilocybin therapy in cancer care
From Dr. Anthony Back and the Gooley Group, Clinical Research Division
How Fred Hutch scientists tackle world’s top infectious killer, TB
Expertise in immunology and biostatistics underpin foundational work in tuberculosis vaccines, biomarkers and pathology that could usher in a new era
Fred Hutch collaboration reveals molecular vulnerability in rare childhood brain cancer
Researchers uncover a weak link in tumors driven by a notorious gene fusion that could be targeted with a drug
Fred Hutch hematologists featured at 2026 Tandem Meetings
Researchers highlight findings on making stem cell transplants safer and more effective
Giving CAR T cells a portable pit crew
Fred Hutch scientists dig deep into the biology of CAR T-cell exhaustion and examine experimental strategy to improve the immunotherapy for solid tumors
Fred Hutch biochemist eavesdrops on cellular debate about where to start translating genetic messages
Study sheds light on how translation start-site selection can go awry in cancer and other diseases
Fred Hutch researchers test privacy-first AI platform for cancer research
After a year of building the infrastructure for its federated learning platform, the Cancer AI Alliance (CAIA) is road-testing eight projects using de-identified clinical data from four comprehensive cancer centers
Taming viral threats after lifesaving transplants
From the Boeckh Lab, Vaccine and Infectious Disease Division
Exposing viral vulnerabilities for targeted cancer vaccines
From the Boonyaratanakornkit, Phipps, Pancera, and McGuire Labs, Vaccine and Infectious Disease Division
Fred Hutch announces 12 recipients of the annual Harold M. Weintraub Graduate Student Award
Award recognizes innovative research by graduate students in biological sciences
Dr. Holly Harris awarded the inaugural Bus Family Endowed Chair for research on women’s health
Fred Hutch endowed chair to focus on gynecologic cancers and related conditions
Space Invaders: Extracellular bacterial occupation alters tumor fate
From the Bullman Lab, Human Biology Division